ATE312603T1 - Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren - Google Patents

Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren

Info

Publication number
ATE312603T1
ATE312603T1 AT00115601T AT00115601T ATE312603T1 AT E312603 T1 ATE312603 T1 AT E312603T1 AT 00115601 T AT00115601 T AT 00115601T AT 00115601 T AT00115601 T AT 00115601T AT E312603 T1 ATE312603 T1 AT E312603T1
Authority
AT
Austria
Prior art keywords
pets
suppressing
composition containing
behavior disorders
containing theanine
Prior art date
Application number
AT00115601T
Other languages
English (en)
Inventor
Noriyuki Ishihara
Senji Sakanaka
Seiji Shu
Lekh Raj Juneja
Original Assignee
Taiyo Kagaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyo Kagaku Kk filed Critical Taiyo Kagaku Kk
Application granted granted Critical
Publication of ATE312603T1 publication Critical patent/ATE312603T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00115601T 1999-07-19 2000-07-19 Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren ATE312603T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20430799A JP4669095B2 (ja) 1999-07-19 1999-07-19 ペットの問題行動抑制組成物

Publications (1)

Publication Number Publication Date
ATE312603T1 true ATE312603T1 (de) 2005-12-15

Family

ID=16488326

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00115601T ATE312603T1 (de) 1999-07-19 2000-07-19 Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren

Country Status (7)

Country Link
US (1) US6297280B1 (de)
EP (1) EP1074252B1 (de)
JP (1) JP4669095B2 (de)
AT (1) ATE312603T1 (de)
CA (1) CA2313878C (de)
DE (1) DE60024730T2 (de)
ES (1) ES2254078T3 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10035190C5 (de) 2000-07-20 2009-07-16 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren und Vorrichtung zur Fluoreszenzmessung
JP3907964B2 (ja) * 2001-04-25 2007-04-18 株式会社 伊藤園 精神疲労軽減組成物、集中力維持増強組成物及び精神的活力維持増強組成物
JP4812968B2 (ja) * 2001-06-06 2011-11-09 太陽化学株式会社 注意欠陥多動性障害改善用組成物
HUP0401154A2 (hu) * 2001-07-20 2004-10-28 Pfizer Products Inc. NK-1 receptor antagonisták használata kutyák, macskák és lovak nemkívánatos viselkedésének módosítására
US20030194478A1 (en) † 2002-04-12 2003-10-16 Davenport Gary Mitchell Dietary methods for canine performance enhancement
WO2004006688A1 (en) * 2002-07-12 2004-01-22 The Iams Company Synergistic effect of diet and human interaction on the behavior of dogs
US8841344B2 (en) * 2002-10-03 2014-09-23 Hill's Pet Nutrition, Inc. Method of using omega-3 fatty acids
US20050070537A1 (en) * 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8633246B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for osteoarthritis
US8921422B2 (en) 2003-10-01 2014-12-30 The Iams Company Methods and kits for enhancing ability to learn in a puppy or kitten
JP2008169144A (ja) * 2007-01-11 2008-07-24 Ito En Ltd 心的外傷後ストレス障害予防剤、治療剤及び飲食物
US20080299286A1 (en) * 2007-06-04 2008-12-04 David B Josephson Palatability enhancing compositions and foods for pets, and methods regarding the same
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CA2994586C (en) 2008-01-04 2020-07-21 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
DE102015009525A1 (de) 2015-07-17 2017-01-19 Ulrich Jüstrich Holding AG Neuartige Zusammensetzungen zur Anwendung bei prämenopausalen und menopausalen Frauen zur Bereitstellung verbesserter Nahrungsergänzung und/oder Linderung der Menopausesymptome
EP3662919A1 (de) 2015-08-31 2020-06-10 Nutramax Laboratories, Inc. Zusammensetzungen mit magnolie, phellodendron, theanin und/oder molkeprotein
JP2022012658A (ja) * 2020-07-02 2022-01-17 太陽化学株式会社 ペットのアレルギー緩和用経口組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54129130A (en) * 1978-03-27 1979-10-06 Mitsubishi Chem Ind Ltd Method for promoting roughage digestion of animal
GB8601915D0 (en) * 1986-01-27 1986-03-05 Efamol Ltd Pharmaceutical compositions
ES2036910B1 (es) * 1990-10-11 1994-01-16 Quimica Mobi S A Aditivo corrector para piensos a base de cloruro de colina.
JPH06237734A (ja) * 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
JPH05229938A (ja) * 1991-12-25 1993-09-07 Food Design Gijutsu Kenkyu Kumiai 血圧降下剤
JP2904655B2 (ja) * 1992-09-17 1999-06-14 サントリー株式会社 抗ストレス剤
JPH0873350A (ja) * 1994-09-06 1996-03-19 Itouen:Kk 脳機能改善剤、食品及び飲料
JPH08245378A (ja) * 1995-03-09 1996-09-24 Sagami Chem Res Center 精神安定剤
JP4627813B2 (ja) * 1995-06-27 2011-02-09 太陽化学株式会社 テアニン含有組成物
JPH10165109A (ja) * 1996-12-06 1998-06-23 Taiyo Kagaku Co Ltd 飼料組成物及び飼料
JP3731983B2 (ja) * 1997-08-27 2006-01-05 明治製菓株式会社 痴呆犬の夜鳴き改善薬
ATE354359T1 (de) * 1998-02-23 2007-03-15 Taiyo Kagaku Kk Theanin-beinhaltende zusammenstellung
CN1156545C (zh) * 2002-04-30 2004-07-07 姚惠渥 无毒无污染聚苯乙烯涂料及其制备方法

Also Published As

Publication number Publication date
CA2313878C (en) 2008-12-02
EP1074252A3 (de) 2002-01-16
ES2254078T3 (es) 2006-06-16
US6297280B1 (en) 2001-10-02
EP1074252A2 (de) 2001-02-07
DE60024730D1 (de) 2006-01-19
DE60024730T2 (de) 2006-08-03
CA2313878A1 (en) 2001-01-19
EP1074252B1 (de) 2005-12-14
JP2001031566A (ja) 2001-02-06
JP4669095B2 (ja) 2011-04-13

Similar Documents

Publication Publication Date Title
ATE312603T1 (de) Theanin enthaltende zusammensetzung zur unterdrückung von verhaltensstörungen der haustieren
US5091171B1 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
DE60027405D1 (de) Verfahren zur steigerung der aktivität von haustieren
DE3683374D1 (de) Mikrobielle zusammensetzungen und verfahren zur behandlung vom boden.
DE3882245D1 (de) Magnetoresistiver kopf und verfahren zu seiner herstellung.
ATE133534T1 (de) Antimikrobizides gemisch
ATE163259T1 (de) Mittel zur regulierung vom hautfettigkeitsgrad
ATE120482T1 (de) Enzymatisches verfahren zur verminderung des gehaltes an phosphorhaltigen bestandteilen in pflanzl. u. tierischen olen.
ATE96313T1 (de) Fettsaeure-zusammensetzungen.
FI20021947A0 (fi) Menetelmä triglyseridien rasvahappoketjukoostumuksen säätämiseksi sekä menetelmän käyttö
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DE3581417D1 (de) Lateraler bipolarer transistor und verfahren zu seiner herstellung.
DE3682959D1 (de) Bipolarer transistor mit heterouebergang und verfahren zu seiner herstellung.
DE69832520D1 (de) Verwendung von konjugierten linoleinsäure zur behandlung von type ii diabetes
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
BR9810567A (pt) Composições antimicrobianas sinérgicas contendo uma dimetilamida de um ácido carboxìlico com uma mistura de 2-(tiocianometiltio) benzotiazol e um metileno-bis (tiocianato) e uso destes
DE69420961D1 (de) Zusammensetzungen zur duftfreisetzung die geringe mengen von fluechtigen organischen komponenten enthalten
DE69828191D1 (de) Verfahren zur herstellung von 2,6-dialkylnaphthalin
ATE228780T1 (de) Fettsäuren als eine nährungsergänzung
BR0107544A (pt) Composição de promoção de secreção de bile
DE60015791D1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE3881533D1 (de) Tiermedizinische zusammensetzung zur verhinderung von diarrhoe bei tieren.
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
DE69812438D1 (de) Zusammensetzung zur herstellung von brennstoff-briketts
ATE345121T1 (de) Verwendung von konjugierter linolsäure zur behandlung der erkältung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties